chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bronchitis symptoms, tightness in chest, coughing back pain, temperature 3 points above normal, sweating. Saw doctor 9/5/17 - could not rule out pneumonia. Prescribed Azithromycin 250mg pack, DIFLUCAN 150 mg, PROAIR HFA. Gradual improvement since then.
Information regarding Flumist was received from a healthcare professional regarding a 31 year old female pt who experienced mouth numbness, tingling of mouth and headache. At 31 years of age, the pt received the first dose on 12/10/03. Five minutes post-immunization, the pt experienced mouth numbness, tingling of mouth and headache. The reporter indicated that the pt was not allergic to eggs and has no history of reactive airway disease. The reporter also indicated that the pt has never had influenza vaccine prior to this event. No additional info was available at the time of this report.
side effects too awful/terrible side effects; they were sick for two days; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (they were sick for two days) and FEELING ABNORMAL (side effects too awful/terrible side effects) in a female patient of an unknown age who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (they were sick for two days) and FEELING ABNORMAL (side effects too awful/terrible side effects). At the time of the report, ILLNESS (they were sick for two days) had resolved and FEELING ABNORMAL (side effects too awful/terrible side effects) outcome was unknown.        For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  Patient received Moderna booster dose.  It was reported that side effects too awful and they would not get another one.   It was reported that side effects are just too much when they received the moderna booster shot.   Treatment medication was not provided by the reporter.
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Rash appears again and itches him.) and RASH (rash between her ankles and knees (on both legs)) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced PRURITUS (Rash appears again and itches him.). On 19-Mar-2021, the patient experienced RASH (rash between her ankles and knees (on both legs)). At the time of the report, PRURITUS (Rash appears again and itches him.) and RASH (rash between her ankles and knees (on both legs)) had not resolved.    Concomitant product use was unknown by the reporter. Treatment medication include Benadryl and alcohol.
Headache & Myalgia Narrative: Patient reports symptoms of headaches and muscle/body aches which began within 3 hours of receiving second dose of COVID-19 vaccine. Reports used Aleve (naproxen; no dose of frequency provided) for symptoms. Reports had not fully recovered as of date of report, but did not need to report to PCP or urgent care. Reports experienced similar symptoms (primarily headache) with first dose of vaccine.
I had right knee replacement surgery in 2018 and developed severe neuropathic pain in right leg . He pain subsided with time . After I got vaccine the pain came got . Now I have tingling , electrical like feeling , hot foot. I am applying ice. It tweaks me up at night.It is annoying
Information has been received from an attorney on behalf of representatives of the estate of a patient who, on 10/19/1998, was vaccinated with a dose of hepatitis B virus vaccine. Subsequently, the patient experienced an unspecified injury. Additional information was received concerning hep b vaccine. It was not indicated if the pt received lot 626311/043H or lot 4949H. Additional information was received regarding Hib conj vaccine. It was not indicated if the pt received Hib conj vaccine.  Upon internal review the unspecified injury was considered an other important medical event. (OMIC) Additional information will be provided when it becomes available.
Red blister on right anterior thigh began on 9/26/14. Following by crusting area approx 1/4 inch to redness on the outside to total size of 1/2 inch. Redness on outside begain on 10/5/14.
#1 Vaccine - Needle was too long. Administered in Left bicep. Pain onset following the injection and continues today 3.5 weeks later.  Not relieved by Ibuprofen po or arthritis pain topical gel ( Diclofenac Sodium Topical Gel).  #2 Vaccine - needle was 5/8".  Administered in Right bicep.  Slight discomfort in muscle following injection.  Otherwise no problem.
I was instructed to submit this VAERS by our infectious disease specialist. Patient with possible pericarditis.  Per ER note 9/1/2021: "This is a 31 years old female, with a PMHx of depression, and IBS, who presents to the ED for evaluation of chest pain.  She describes it as not dull or sharp, just "pain."  Laying down seems to exacerbate symptoms.  Additionally, she is also experiencing headaches, light sensitivity, body aches, nausea, and has a low grade fever.  She denies any soreness to touch.  2 days ago, she received her second COVID vaccine"
pt recvd vax & devel a 4 centimeter area of painful induration, redness & warmth @ the inject site;
Night sweats, fever, cough, chills,  swollen lymph nodes, mass located on lymph node
I've had vertigo at random times ever since.; At time of injection there was an immediate tingling sensation throughout the entire lining between my skull and brain that lasted a few seconds; 30 seconds later the room seemed to be swaying; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 07Aug2021 10:00 (Lot number: FA7484) at the age of 57 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]; IRON; ZINC; CALCIUM; POTASSIUM. Past drug history included: Known allergies: penicillin, reaction(s): "Allergy", notes: known allergies: penicillin. The following information was reported: VERTIGO (non-serious) with onset 07Aug2021 10:00, outcome "not recovered", described as "I've had vertigo at random times ever since."; PARAESTHESIA (non-serious) with onset 07Aug2021 10:00, outcome "recovered" (07Aug2021), described as "At time of injection there was an immediate tingling sensation throughout the entire lining between my skull and brain that lasted a few seconds"; DIZZINESS (non-serious) with onset 07Aug2021 10:00, outcome "not recovered", described as "30 seconds later the room seemed to be swaying". Therapeutic measures were not taken as a result of vertigo, paraesthesia, dizziness.  Additional information: Facility where the most recent COVID-19 vaccine was administered Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. At time of injection there was an immediate tingling sensation throughout the entire lining between my skull and brain that lasted a few seconds. 30 seconds later the room seemed to be swaying. That lasted a few seconds. However, I've had vertigo at random times ever since. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Relevant Tests: Unknown.  No follow-up attempts are possible. No further information is expected.
pt recv vax & w/in 10min pt exp chest tightness & SOB;med given & MD notified more tx given & breathing returned to nl p/waiting 1hr;
Urticaria and blocked nose. Shot given and pt symptomatic in 1-2 hrs. Seen and treated in Er (WHMC)
12 hours after injection - arm in severe pain, severe headaches, fever, body aches, chills, generalized joint pains
Prior to receiving Pfizer bivalent shot, patient stated previous Covid shots "became mild lightheaded and mils fluttering in chest." States her Healthcare Provider is aware and has OK'd booster shot to be given today. Patient also confirmed with her Nurse that it is OK to receive Covid booster today. At 11am Pfizer bivalent booster shot given. At 11:45am states "feels light headed and has mild fluttering in chest".  B/p 150/90. Escorted patient to Nurse office to rest and lie down. Monitored patient. At 12;05pm Nurse took B/p 150/90 and heartrate 102. Patient states has not eaten for a few days. Juice encouraged and given at this time and tolerated juice well. At 12:15pm B/p 150/85 and patient feeling about the same. Nurse and patient decided it was OK for patient to go home and rest. nurse stated she will be checking in on patient by phone. Nurse called today to check status of patient.  Nurse stated  patient stayed home today to rest. Nurse will me if any changes occur.
pt recv vax & 1hr post vax broke out in fine bumps & itching;rash never got as bad as 1st time;rash went away quicker w/DPH MD advised not give anymore;
Gave booster at 4 months instead of 5. Upon follow-up 5 hours later, patient reported she felt fine.
Received the 2nd dose yesterday and when I woke this morning I had a headache, body ache, extremely sore arm, fever (99.8), nausea, chills.  I took something for nausea and two extra strength Tylenol and have just been drinking a lot of water.  The medicine helped with the fever and nausea
Student's arm became red and swollen. Student saw Physician and was prescribed antibiotics. Student recovered.
Patient presents with redness on her left arm 2 days after receiving this vaccine . She said she could barely lift her left arm on the previous day. She said she felt better today. However, her arm felt warm and tender after touching it. This is a mild case of cellulitis based on patient's symptoms. I referred her to her doctor for treatment immediately
This spontaneous report as received from a registered nurse refers to a 16-year-old female patient. The patient's current condition included primary immune deficiency. Her pertinent medical history included repeated infections. She had no known drug reactions or allergies. On 27-DEC-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 (exact dose, dose number, route of administration were not reported; lot # N012127 with the expiration date of 20-JAN-2019) in the left deltoid, for primary immune deficiency. Concomitant therapies included midodrine hydrochloride (MIDRON, reported as "MIDRONE") and fluoxetine. On 08-JAN-2018, the patient had a a fever of 99.8 Fahrenheit degrees. The injection site became painful, red, swollen and hot to touch. On 08-JAN-2018, the patient was diagnosed with cellulitis by an unspecified healthcare provider and on the same day, admitted to a hospital. On 08-JAN-2018, the patient had a surgical drainage of the left arm, which yielded pus but had negative cultures. The patient was prescribed an unspecified 10-day course of clindamycin by an unspecified healthcare provider on an unspecified date in January 2018. On 11-JAN-2018, the patient's fever, pain and swelling improved, but did not resolve (present status was reported as recovering). It was not reported if the patient was discharged from the hospital. The causality assessment between cellulitis and PNEUMOVAX 23 was not provided. The reporter considered the event of cellulitis to be a significant disability or incapacity, as the patient was not able to move her arm. Upon internal review, the event of cellulitis was considered to be medically significant.
This spontaneous report as received from a pharmacist refers to a 56 year old female patient. On 30-JUN-2014, the patient was vaccinated with a dose of ZOSTAVAX (1 standard pack vial of 1) 0.65 ml dose, once, subcutaneously (lot number reported as K00327, exp. date reported as March 2015 (indication and anatomical location not reported). On 01-JUL-2014, the patient presented to pharmacy with a possible injection site reaction which was really big, red and itchy and warm. The patient additionally reported that she experienced headache, fever and felt weak. The outcome of events was reported as not recovered/not resolved and the events remained ongoing. There was no treatment given for the event. There was no intervention to prevent serious criteria. The relatedness between the events and ZOSTAVAX was not reported. Lot number K00327 is an invalid lot number for ZOSTAVAX. Additional information has been requested.
Present to the clinic at 12:30am on 12/6/17 with complaints of redness, swelling, and pain in her right upper arm at the injection site. Site assessed. 8cm by 8cm erythema, edematous, tender areas, with slight tightness of the skin. I obtain an xray of her upper arm and placed her on BACTRIM. She is to return to the clinic in 2 days.
Information has been received from a physician's assistant concerning a female patient who in October 2008 was vaccinated with the third dose of GARDASIL (lot number not reported). In December 2008, the patient developed low-grade SIL. At time of reporting the outcome was unknown. The patient sought unspecified medical attention. Follow up information was received from the physician's assistant who reported the patient was intramuscularly vaccinated with the second dose of GARDASIL (lot # 0152X) into the left deltoid at 10:00 on 12-JUN-2008. At 08:00 on 13-JUN-2008 the patient developed hive like lesion on left deltoid to left arm and mild itching. It lasted half of a day and went away by itself. The patient did not call medical office for reporting the above symptoms. Additional information is not expected.
Pain, redness, warmth, swelling at injection site. Started day after injection was given and continued for at least 2 days.
Noted diffuse urticaria and wheals to upper thighs, face, lower back and buttocks after flu vaccine given. Treated with benadryl, ice packs. No wheezing or facial swelling.
Lower leg down to foot had a burning, severe pain. Healthcare professional diagnosed with nerve damage.  Currently seeing a Neurosurgeon. Dr.
Client felt lightheaded when asked how she was feeling. She was immediately advised to put her vehicle in park. Client started seizing and  nurse was called over. Her eyes were rolling and her muscles were tightening up. ALS called over. Client regained consciousness but was confused. Fire Dpt. and ambulance was called as well. PT moved to stretcher. While being moved, car seat was noted to be wet. ALS took PT to ambulance, patient transported  to local hospital.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Severe, Additional Details: PATIENT FELT LIGHT HEADED AND DIZZY THEN FAINTED AND VOMITED INTO HER MASK AND ALL OVER HER CLOTHING. CHECKED BP WAS 108/68 AND LATER INCREASED TO 108/86. PATIENT LEFT AFTER 30 MINUTES FEELING EXTREMELY FATIGUED. COUNSELLED TO CONTACT PCP ASAP
Myalgia, left injection site and left arm pit - swelling, tenderness, pain , with slight chills, tiredness, strated noticining it last wednesday and not subsidedd
Information has been received from a physician concerning a 14 year old male who on 05-SEP-1997 was vaccinated with a first dose of VARIVAX (Merck) and the second dose was administered on 3-OCT-2008 (doses, routes and lot numbers unspecified). On 19-MAY-2009, the patient was diagnosed with shingles. The outcome of the patient was not recovered. The patient sought unspecified medical attention. Additional information has been requested.
Found unresponsive in vehicle, CPR initiated within 5 min. Resuscitated from cardiac arrest in ER at Medical Center. Suffered anoxic brain injury. As inpt had ventricular tachycardia, ventricular fib. Post-mortem exam revealed 3-vessel coronary artery disease, left ventricular hypertrophy, cardiomegaly, but no myocarditis. Full records provided to Dr.
stiffen up   eyes rolled back  pt unresponsive for 5 to 10 sec  given ice pack and held to back of neck prior to administration pt was pale and sat for 25 minutes after dose  pt had the same reaction to first shot  and has it to all shots
(L) arm pain, reddened area warm and hard to touch, lump - 15x15 mm
covid test result=Positive; covid test result=Positive; Maternal Exposure During Pregnancy, second trimester; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Jul2021 (Batch/Lot number: unknown) at the age of 32 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Date of last menstrual period: 07Aug2021. The patient is expected to deliver a baby(s) on 14May2022. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Left), administration date: 21Jun2021, when the patient was 32 years old, for COVID-19 immunization. The following information was reported: VACCINATION FAILURE (hospitalization, medically significant) with onset 04Jan2022, outcome "unknown", COVID-19 (hospitalization, medically significant) with onset 04Jan2022, outcome "recovered with sequelae" (2022) and all described as "covid test result=Positive"; MATERNAL EXPOSURE DURING PREGNANCY (non-serious) with onset 21Jul2021, outcome "unknown", described as "Maternal Exposure During Pregnancy, second trimester". The patient was hospitalized for vaccination failure, covid-19 (hospitalization duration: 2 day(s)). The event "covid test result=positive" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: body temperature: (03Jan2022) fever; sars-cov-2 test: (04Jan2022) positive, notes: Nasal Swab. Therapeutic measures were taken as a result of covid-19.  Clinical course: Facility type vaccine was reported in Workplace clinic. Patient received no other vaccine in four weeks. Patient received no other medications in two weeks. The patient had covid prior vaccination. The patient was tested covid post vaccination. Adverse events included hard time breathing and hospitalized, headache with fever, cough, muscle aches, fatigue. AE treatment included albuteral inhaler.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Left arm became red and swollen.  Progressed for a day to the point where in involved upper arm to the elbow, left shoulder into the pectoralis muscle.
post herpetic neuralgia; multiple outbreaks of herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently approximately 78-year-old patient (pt) of unknown gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 28-FEB-2007, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date (reported as subsequently), the pt was treated by providers for the following injuries resulting from pt's zoster vaccine live (ZOSTAVAX) use: multiple outbreaks of herpes zoster and post herpetic neuralgia. The outcome of the events was not reported. The lawyer considered the events to be related to zoster vaccine live (ZOSTAVAX).
Slight soreness following injection (R) upper arm (Right). 24 hr post injection developed increased R upper arm pain, R shoulder pain, neck pain, R upper arm rash - red raised bumps & welts. No generalized rash, no fever, no enlarged lymph nodes. Some improvements at 72 hours with ACETAMINOPHEN.
Developed Covid 19 infection 28 days after Johnson and Johnson vaccination. This was further complicated by bilateral pulmonary embolism requiring mechanical thrombectomy and ICU admission.
Case number PHHY2011US69369, is an initial spontaneous report from a physician received on 29 July 2011: This report refers to a child. This child was vaccinated with only the MenCWY liquid conjugate component of MENVEO (batch number unknown) 0.5 mL, intramuscularly without being reconstituted with the MenA conjugate component on 22 Jul 2011. No adverse events were noted following this medication error.
Diffuse leg swelling from point of injection in ant thigh distally to knee, mild erythema/tenderness.
measles; This spontaneous report was received from a nurse via a company representative and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously (strength, exact dose, lot# and expiry date were not reported) for measles, mumps and rubella virus.  On an unknown date, the patient developed measles.  The outcome of measles was reported as not recovered. The causality assessment was not reported.  Upon internal review, the event of measles was considered to be medically significant.
Took 2nd vaccine (Modena) for Covid19 and was admitted to hospital within 3 weeks for Myocarditis // suspected Myocarditis. I don't have information available to me but the tests and lab work showed elevated inflammatory issues that led them to diagnose with suspected myocarditis. I also had an MRI to ensure I had not had any strokes.
itchy bumps/hives on arms around injection site, left and right arms, left and right legs on knees and behind knees, chest, belly, neck, back
PRESENTED TO ED WITH DYSPNEA, TESTED COVID19 POSITIVE. DEVELOPED ACUTE RESP FAILURE AND DIED 9/11/21
A non-serious spontaneous report of we gave 14 doses of expired FLUMIST was received from a health professional concerning a five-year-old female. Neither the patient's medical history nor concomitant medications were reported. The product expired on 22-Jan-2012. On 27-Jan-2012, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
HIVES BEGAN TWO DAYS AFTER INNOC. REPORTING PHYSICIAN(VACCINEE) FOUND TO BE REACTION OF HIVES TO INSECTS.
4d after vaccination patient started experiencing nosebleeds (lasting ~10 minutes with compression) and developed petechiae on her hand. Recommended ER for evaluation and laboratory work (CBC/CMP) after discussion
About 12 hours after the injection she developed throat tightening and hallucinations about 3 hours prior. Patient watched her oxygen stats from home with a home pulse ox machine. Patient did not take any medications. Patient had symptoms for about 12 hours once they started.